Boston AI Company Speeds Up Parkinson's Cell Therapy

A Boston biotech firm is using artificial intelligence to fast-track stem cell treatments for Parkinson's disease, potentially cutting years off development time.

The breakthrough could bring hope to millions living with the condition.